Change in the Definition of a “Medically Accepted Indication”
Guidance for: Part D sponsors on the implementation of the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) to revise the definition of the term “medically accepted indication” for Part D drugs used in anticancer chemotherapeutic regimens. This provision takes effect on January 1, 2009.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: December 09, 2008
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.